ArticleFuture oncology (London, England)2025

Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01).

Ali Shamseddine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.